Detalhe da pesquisa
1.
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(5): 668-75, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24462743
2.
Interleukin-2 and regulatory T cells in graft-versus-host disease.
N Engl J Med
; 365(22): 2055-66, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22129252
3.
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.
Biol Blood Marrow Transplant
; 18(4): 565-74, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21875503
4.
Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097.
Mol Cancer Ther
; 14(10): 2249-59, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206331
5.
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.
J Clin Invest
; 123(9): 3756-65, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23912587
6.
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.
J Clin Oncol
; 30(26): 3202-8, 2012 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869883
7.
PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
J Invest Dermatol
; 130(9): 2222-30, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20445553